Immunohistochemistry of primary lymphoma entities stained for cytoplasmic-LC3B was significant in 70.6% of aggressive compared to 32.3% of indolent lymphomas (Fig. 1A, B, Supplementary Fig. 1A, B). This evidence concerns the gene MAP1LC3B and lymphoma.